Nissan Chemical Eyes Global Expansion of High-Performance, Cost-Effective Cell Culture Supplement Oct. 7, 2019 Filed Under: Industry Tagged With: cell culture, cells, ES cells, iPS cells, Nissan Chemical, regenerative medicineNissan Chemical Corp. (TYO:4021) is looking to ramp up its global rollout of Stemup, a cell culture preparation supplement for…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Tosoh Enables Simple Removal of Regenerative Medicine Cells…Tokyo Institute of Technology, Kanto Chemical Develop Growth…Mitsubishi Chemical to Produce Regenerative Medicine…Ube Industries Readies for Launch Into BiopharmaceuticalsLSII to Launch Clinical Trials of Muse Cells to Treat…Menard, Mandom Expand Cosmetics Research to Look at Stem…